Is Invesco (IVZ) a risky stock?
As of July 21, 2026, Clavix grades Invesco (IVZ) C for risk, a composite score of 59 out of 100 on an A+ to F scale, which puts IVZ in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind IVZ's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how IVZ scores on each, as of July 21, 2026.
What's moving IVZ's risk right now
Company-specific signals Clavix flags behind IVZ's current grade, drawn from recent news and filings as of July 21, 2026.
Invesco's new QQA Nasdaq-100 ETF offers monthly distributions but limits gains and holds a large cash position, targeting income-focused investors. Separately, Morgan Stanley raised its IVZ price target to $30 while staying neutral on the stock.
Invesco hired Northern Trust to provide administration, custody and depositary services for a new set of Irish mutual funds that use swap-based index replication. It's a routine operational step that expands IVZ's product lineup without a clear stock impact.
What a C grade means
On the Clavix A+ to F scale, IVZ's composite of 59 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell IVZ or any security. Grades are risk indicators, not predictions of return. Data may be delayed.